isosorbide dinitrate has been researched along with cellulose in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danjo, K; Kitamura, Y; Miyagawa, Y; Otsuka, A | 1 |
Kuo, JF; Woo, EM; Yang, GM | 1 |
Chen, Q; Gan, L; Gan, Y; Ma, S; Xie, H | 1 |
Fang, Z; Huang, G; Wang, R | 1 |
Guan, T; Han, D; He, H; Li, G; Tang, X; Zhao, X | 1 |
Chi, Q; Du, L; Jiang, Q; Li, X; Wang, C | 1 |
Ge, L; Gong, Y; Jiang, L; Liu, J; Liu, Q; Shi, Y; Zheng, C; Zhu, J | 1 |
Du, L; Jiang, Q; Li, M; Li, X; Li, Y | 1 |
2 trial(s) available for isosorbide dinitrate and cellulose
Article | Year |
---|---|
In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.
Topics: Adult; Area Under Curve; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diuretics; Drug Delivery Systems; Drug Stability; Drug Storage; Humans; Isosorbide Dinitrate; Male; Membranes, Artificial; Osmosis; Pharmaceutic Aids; Povidone; Solutions; Young Adult | 2012 |
Evaluation of novel immediate-/controlled-release tablets of isosorbide-5-mononitrate (5-ISMN): in vitro-in vivo correlation.
Topics: Adult; Algorithms; Area Under Curve; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Cross-Over Studies; Delayed-Action Preparations; Drug Delivery Systems; Excipients; Half-Life; Humans; Isosorbide Dinitrate; Male; Molecular Weight; Osmosis; Polyethylene Glycols; Solubility; Tablets; Vasodilator Agents; Young Adult | 2014 |
6 other study(ies) available for isosorbide dinitrate and cellulose
Article | Year |
---|---|
Release of isosorbide dinitrate from polymer film dosage forms and absorption of this drug through the oral mucosa of rats.
Topics: Absorption; Animals; Cellulose; Delayed-Action Preparations; Dosage Forms; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hypromellose Derivatives; Isosorbide Dinitrate; Male; Methylcellulose; Mouth Mucosa; Polymers; Rats; Structure-Activity Relationship | 1994 |
Preparation and control-release kinetics of isosorbide dinitrate microspheres.
Topics: Cellulose; Delayed-Action Preparations; Diffusion; Drug Compounding; Excipients; Hypromellose Derivatives; Isosorbide Dinitrate; Kinetics; Methylcellulose; Microscopy, Electron, Scanning; Microspheres; Particle Size; Porosity; Solubility; Spectrophotometry, Ultraviolet; Vasodilator Agents | 2006 |
Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network.
Topics: Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Excipients; Food-Drug Interactions; Isosorbide Dinitrate; Models, Biological; Neural Networks, Computer; Starch; Tablets; Time Factors | 2008 |
[Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
Topics: Capsules; Cellulose; Delayed-Action Preparations; Drug Carriers; Hypromellose Derivatives; Isosorbide Dinitrate; Methylcellulose | 2008 |
Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
Topics: Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug Storage; Excipients; Humidity; Isosorbide Dinitrate; Polymethacrylic Acids; Povidone; Solubility; Technology, Pharmaceutical; Temperature | 2010 |
A novel multi-unit tablet for treating circadian rhythm diseases.
Topics: Administration, Oral; Angina Pectoris; Cardiovascular Agents; Cellulose; Chemistry, Pharmaceutical; Chronobiology Disorders; Delayed-Action Preparations; Drug Carriers; Excipients; Hypromellose Derivatives; Isosorbide Dinitrate; Kinetics; Methacrylates; Methylcellulose; Microscopy, Electron, Scanning; Polymers; Solubility; Tablets; Technology, Pharmaceutical | 2013 |